$6.19 Million is the total value of ABG-WTT Global Life Science Capital Partners GP Ltd's 3 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MDVL | MEDAVAIL HOLDINGS INC | $4,505,838 | -61.4% | 15,029,480 | 0.0% | 72.83% | +0.0% | |
| RAPID MICRO BIOSYSTEMS INC | $1,173,274 | -65.0% | 1,038,296 | 0.0% | 18.96% | -9.4% | ||
| LUNG | PULMONX CORP | $507,520 | -49.4% | 60,204 | 0.0% | 8.20% | +31.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MEDAVAIL HOLDINGS INC | 12 | Q3 2023 | 92.0% |
| PULMONX CORP | 12 | Q3 2023 | 49.0% |
| RAPID MICRO BIOSYSTEMS INC | 7 | Q3 2023 | 57.2% |
| RAYZEBIO INC | 1 | Q3 2023 | 83.0% |
View ABG-WTT Global Life Science Capital Partners GP Ltd's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 4 | 2023-06-21 |
| 13F-HR | 2023-05-15 |
| 4 | 2023-03-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View ABG-WTT Global Life Science Capital Partners GP Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.